Clinical trials
Phase 1 trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
422 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 7 |
| 2007 | 8 |
| 2008 | 9 |
| 2009 | 33 |
| 2010 | 35 |
| 2011 | 33 |
| 2012 | 28 |
| 2013 | 21 |
| 2014 | 17 |
| 2015 | 24 |
| 2016 | 24 |
| 2017 | 19 |
| 2018 | 23 |
| 2019 | 19 |
| 2020 | 16 |
| 2021 | 26 |
| 2022 | 22 |
| 2023 | 16 |
| 2024 | 7 |
| 2025 | 17 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 280 |
| Terminated | 47 |
| Active, not recruiting | 28 |
| Recruiting | 26 |
| Unknown status | 26 |
| Withdrawn | 10 |
| Suspended | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 100 |
| Pfizer | 60 |
| Novartis Pharmaceuticals | 53 |
| National University Hospital, Singapore | 36 |
| National Cancer Centre, Singapore | 18 |
| Bayer | 15 |
| Hoffmann-La Roche | 11 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 11 |
| Singapore National Eye Centre | 8 |
| Amgen | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 30 |
| Neoplasms | 21 |
| Diabetes Mellitus, Type 2 | 20 |
| Breast Neoplasms | 14 |
| Colorectal Neoplasms | 13 |
| Carcinoma, Hepatocellular | 12 |
| Triple Negative Breast Neoplasms | 12 |
| Neoplasm Metastasis | 11 |
| Obesity | 11 |
| Hepatitis B, Chronic | 10 |
Trials
Showing 76 to 100 of 422. Each trial links to its page on Pharma Observatory.
322 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.